CANCER THERAPY

Brand	Owner (click to sort)	Address	Description
IRT	AltaRex Corp.	Campus Tower Suite 300 8625-112 St. Edmonton, Alberta T6G 2E1 Canada	cancer therapy, namely, the use of mono clonal antibodies and radioisotopes in humans to combine the therapeutic effects of the mono clonal antibody and radioisotopes;
PROLYSIN	Idec Pharmaceuticals Corporation	3030 Callan Road San Diego CA 92121	cancer therapy, pharmaceuticals and diagnostics;
	Where the owner name is not linked, that owner no longer owns the brand

Technical Examples

Novel monoclonal antibodies and binding fragments thereof specific to human breast cancer, lung cancer, colon cancer and other cancers. The monoclonal antibody does not bind to the cell surface of normal human tissues. The corresponding cancer-specific antigen with an apparent molecular weight of 150 kd and polynucleotides encoding the antigen and the CDR regions of the antibody are Also disclosed are methods for diagnosis, prognosis and treatment of human breast cancer. The antibodies have tumor specificity and are useful for therapy, diagnosis, monitoring, detecting and imaging of cancers. The antibody-recognized cancer-specific surface antigens can serve as targets for detecting, diagnosing, inhibiting or killing cancer cells.